*X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia

The trials here

What the 2 trials at this site are about, from their registry records.

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Hoffmann-La Roche2 trials

Running trials

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors

  NCT04434092· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

  NCT04432584· Phase 3· Hoffmann-La Roche· Source